{"id":"W2563380092","doi":"10.1183/13993003.congress-2015.oa265","title":"Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial","year":2015,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Rash; Clinical endpoint; Discontinuation; Lung cancer; Erlotinib; Incidence (geometry); Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008069301,0.0006130762,0.0009560183,0.0002110681,0.0002230256,0.0006692794,0.0004176226,0.0008306939,0.004146175],"category_scores_gemma":[0.0006640504,0.0002154164,0.001100636,0.0002201949,0.0002800958,0.0005788865,0.0001865323,0.001553595,0.0005982136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004605403,"about_ca_system_score_gemma":0.0006285423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004525455,"about_ca_topic_score_gemma":0.001413891,"domain_scores_codex":[0.9998125,0.00009454539,0.00001561354,0.00003259521,0.00001448347,0.00003013362],"domain_scores_gemma":[0.9996572,0.0000754662,0.00009607036,0.0000194064,0.00001911561,0.0001329104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8863696,0.01040984,0.002386999,0.001106431,0.001361019,0.00009704599,0.00007772806,0.00118368,0.01158495,0.0001905303,0.002790224,0.08244196],"study_design_scores_gemma":[0.7554522,0.2306916,0.006103872,0.0001064225,0.0009817398,0.0002809989,0.00006106593,0.001350744,0.002217053,0.0002758526,0.002455182,0.0000232938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908456,0.005164452,0.0002579688,0.0005242741,0.0001963654,0.000634724,0.0006010126,0.0000561035,0.001719601],"genre_scores_gemma":[0.9936644,0.0022751,0.0004672534,0.00052752,0.0001239989,0.0005910139,0.0005797227,0.000009367798,0.001761589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004146175,"threshold_uncertainty_score":0.01387036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01997867944430442,"score_gpt":0.3264943260710871,"score_spread":0.3065156466267827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}